101 related articles for article (PubMed ID: 8917631)
1. Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cells.
Cardillo M; Yankelevich B; Mazumder A; Lupu R
Cancer Immunol Immunother; 1996 Sep; 43(1):19-25. PubMed ID: 8917631
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events.
Fady C; Gardner A; Gera JF; Lichtenstein A
Cancer Immunol Immunother; 1993 Oct; 37(5):329-36. PubMed ID: 8104695
[TBL] [Abstract][Full Text] [Related]
3. Resistance of HER2/neu-overexpressing tumor targets to lymphokine-activated-killer-cell-mediated lysis: evidence for deficiency of binding and post-binding events.
Fady C; Gardner A; Gera JF; Lichtenstein A
Cancer Immunol Immunother; 1993 May; 36(5):307-14. PubMed ID: 8097427
[TBL] [Abstract][Full Text] [Related]
4. Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-overexpressing cells.
Fady C; Gardner AM; Gera JF; Lichtenstein A
Cancer Res; 1992 Feb; 52(4):764-9. PubMed ID: 1346583
[TBL] [Abstract][Full Text] [Related]
5. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
[TBL] [Abstract][Full Text] [Related]
6. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
[TBL] [Abstract][Full Text] [Related]
7. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
[TBL] [Abstract][Full Text] [Related]
8. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
Quillet-Mary A; Cavarec L; Kermarrec N; Marchiol-Fournigault C; Gil ML; Conjeaud H; Fradelizi D
Int J Cancer; 1991 Feb; 47(3):473-9. PubMed ID: 1704356
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.
Haustein M; Ramer R; Linnebacher M; Manda K; Hinz B
Biochem Pharmacol; 2014 Nov; 92(2):312-25. PubMed ID: 25069049
[TBL] [Abstract][Full Text] [Related]
10. Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].
Staebler A; Sommers C; Mueller SC; Byers S; Thompson EW; Lupu R
Breast Cancer Res Treat; 1994; 31(2-3):175-82. PubMed ID: 7881097
[TBL] [Abstract][Full Text] [Related]
11. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
[TBL] [Abstract][Full Text] [Related]
12. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro.
Budinsky AC; Brodowicz T; Wiltschke C; Czerwenka K; Michl I; Krainer M; Zielinski CC
Int J Cancer; 1997 Jun; 71(6):1086-90. PubMed ID: 9185715
[TBL] [Abstract][Full Text] [Related]
14. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
Jackson AM; Alexandrov AB; Prescott S; James K; Chisholm GD
Immunology; 1992 Jun; 76(2):286-91. PubMed ID: 1353063
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits.
Tagliaferri P; Tortora G; Guarrasi R; Damiano V; Ruggiero A; Morelli D; Caraglia M; Bianco R; di Isernia G; Pepe S; Arteaga CL; Langton-Webster BC; Bianco AR; Ciardiello F
Clin Cancer Res; 1996 Jan; 2(1):207-14. PubMed ID: 9816108
[TBL] [Abstract][Full Text] [Related]
16. Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects.
Campbell SC; Tanabe K; Alexander JP; Edinger M; Tubbs RR; Klein EA
J Urol; 1994 May; 151(5):1385-90. PubMed ID: 7908992
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.
Schellhorn M; Haustein M; Frank M; Linnebacher M; Hinz B
Oncotarget; 2015 Nov; 6(36):39342-56. PubMed ID: 26513172
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
Naganuma H; Kiessling R; Patarroyo M; Hansson M; Handgretinger R; Grönberg A
Int J Cancer; 1991 Feb; 47(4):527-32. PubMed ID: 1671670
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
Donskov F; Basse PH; Hokland M
Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
Bendall LJ; Kortlepel K; Gottlieb DJ
Leukemia; 1995 Apr; 9(4):677-84. PubMed ID: 7723403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
